Tonix Pharmaceuticals exhibits extremely high price volatility, a characteristic common among micro-cap and clinical-stage biotechnology equities traded on major public exchanges. Share valuations can swing dramatically within single trading sessions in response to news items concerning clinical trial readouts, FDA regulatory announcements, secondary public offerings, or broader shifts in speculative market sentiment. Investors tracking the stock must be prepared for steep price fluctuations, wide bid-ask spreads, and rapid shifts in short-term momentum driven by corporate capital-raising activities.